Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP185009.RAu2iPBHmiKnOmGnuyEDNVYOef51jFdhQbhXgOOc-z8Ko130_assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185009.RAu2iPBHmiKnOmGnuyEDNVYOef51jFdhQbhXgOOc-z8Ko130_provenance.
• NP718941.RAiJQ5s5pp2yEMZnngYJz0tah9CGDU2T7-TVVOgc1K3XA130_assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718941.RAiJQ5s5pp2yEMZnngYJz0tah9CGDU2T7-TVVOgc1K3XA130_provenance.
• NP1363035.RADZFxcxH9lH209xHpmpGKX3WHgDqlKBTNxBp3gz0vdjA130_assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1363035.RADZFxcxH9lH209xHpmpGKX3WHgDqlKBTNxBp3gz0vdjA130_provenance.
• NP1363036.RAA5aohEK_6Elfw9LR__geeuAU0hQWAt9Bn8HxgoFmddg130_assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1363036.RAA5aohEK_6Elfw9LR__geeuAU0hQWAt9Bn8HxgoFmddg130_provenance.
• assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1363037.RAU_ybntyhmn-ToBo3n4tebusgAHu02mNzjDZ1ngnSkgY130_assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1363037.RAU_ybntyhmn-ToBo3n4tebusgAHu02mNzjDZ1ngnSkgY130_provenance.
• assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1363034.RAJMWPpwRkjSqqWZQEoklMXZqSUS4E06lZ4-hjt20BtoE130_assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1363034.RAJMWPpwRkjSqqWZQEoklMXZqSUS4E06lZ4-hjt20BtoE130_provenance.
• NP1363039.RAshfYaBj-E28G0NnxmyRUJ0Db4oiGIYKCEP2dt4HOO78130_assertion description "[Loss of heterozygosity (LOH) was analysed in 84 primary tumours from sporadic, familial and hereditary breast cancer using five microsatellite markers spanning the chromosomal region 13q12-q13 which harbours the BRCA2 breast cancer susceptibility gene, and using one other marker located within the RBI tumour-suppressor gene at 13q14.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1363039.RAshfYaBj-E28G0NnxmyRUJ0Db4oiGIYKCEP2dt4HOO78130_provenance.